The major peak of radioactivity from liver extracts appears to behave as a folate polyglutamate on Sephadex G-15, but its behaviour on DEAE cellulose is not consistent with a folate polyglutamate. The second, smaller peak behaved as a monoglutamate on both Sephadex G-15 and DEAE-cellulose, but could not be matched with any authentic folate monoglutamate.
-[14C]methyltetrahydrofolate
The major peak of radioactivity from liver extracts appears to behave as a folate polyglutamate on Sephadex G-15, but its behaviour on DEAE cellulose is not consistent with a folate polyglutamate. The second, smaller peak behaved as a monoglutamate on both Sephadex G-15 and DEAE-cellulose, but could not be matched with any authentic folate monoglutamate.
The present results fail to provide evidence for the formation of folate polyglutamates from orally administered 5-['*C]methyltetrahydrofolate. Both radioactive components from liver remain unidentified. In addition, the results demonstrate the necessity of using more than one chromatographic technique. Chromatography on a single column of either Sephadex G-15 or DEAE-cellulose gives ambiguous results. Methotrexate is known to be a potent inhibitor of dihydrofolate reductase in vitro (Bertino et al., 1965) and has been used to treat a variety of malignant conditions (Ross et al., 1965; Holland & Glidewell, 1972 For control experiments animals received oral doses of water 24h before administration of the folk acid. Total radioactive content of urine, faeces and liver was determined.
Recovery of radioactivity in urine (Table 1) was considerably higher in animals that had received doses of methotrexate than in control animals. The average recoveries being 34 % of the dose after oral methotrexate and 19 % of the dose in control animals, Total recovery of radioactivity in faeces was significantly less in animals that had received methotrexate than in control animals (P< 1 %).
Urine samples were chromatographed on Sephadex G-15 and DEAE-cellulose. Urine samples from control rats gave results similar to those obtained previously in these laboratories (Barford & Blair, 1976) . The major radioactive urinary metabolite was 5-methyltetrahydrofolate. Folic acid, 10-formyltetrahydrofolate, 10-formylfolate and 4a-hydroxy-5-methyltetrafolate were also detected in urine samples from control rats. Urine samples from animals that had received oral doses of methotrexate before ['*C]folic acid were markedly different. In the 0-6h urine sample the major radioactive component was unmetabolized [14C]folic acid, this peak accounted for 90% of urinary radioactivity. In addition, small amounts of 5-methyltetrahydrofolate (approx. 4 % of total), 10-formyltetrahydrofolate (approx. 4% of total), 10-formylfolate and 4a-hydroxy-5-methyltetrahydrofolate were detected. The major radioactive component of the 6-24h urine samples was 10-formyltetrahydrofolate. No folic acid was detected in these urine samples, and two small peaks corresponding to 5-methyltetrahydrofolate and 10-formylfolate appeared on both Sephadex G-15 and DEAE-cellulose columns. Recovery of radioactivity from columns was complete in all cases.
The results reported here demonstrate that there is a measurable effect on [14Clfolic acid metabolism 24h after a dose of methotrexate, as shown by the 0-6h urine samples. We were unable to find any evidence for a build up of dihydrofolate in the rat. None of the expected breakdown products of this compound, such as xanthopterin (Pearson, 1974) , were found in urine samples. All of the radioactivity on columns could be accounted for as folates. This observation suggests that in the normal whole animal any effect of methotrexate on tetrahydrofolate metabolism may not be by inhibition of dihydrofolate reductase, or that cycling of tetrahydrofolates through dihydrofolate may not be a major pathway. In the normal animal, including man, folates in the diet are reduced, therefore, to affect folate metabolism significantly methotrexate must act at the level of the reduced folates. Although we have demonstrated a decreased rate of [14C]folic acid reduction in rats after doses of methotrexate, we have been unable to demonstrate, in the normal animal, any significant disruption in the metabolism of the reduced folates. In the immature female chick the maximum oviduct-growth response to oestrogen cannot be obtained if the birds are folate deficient (Hertz, 1945) . It is also apparent that in the human oestrogens can influence folate status (Larsson-Cohn, 1975) .
In this Department studies over a period of years have attempted to elucidate the nature of the oestrogen-folate interaction in the chicken. Measurement of the amino acid composition of oviducts from oestrogen-treated folate-deficient chicks (Jackson, 1972; Jackson 8c Anderson, 1975) failed to provide direct evidence to suggest that the role of folate in glycine-serine interconversion, methionine synthesis or histidine catabolism was significant in the inhibition of oviduct growth.
The purpose of the present experiments was to investigate the effects of oestrogen and folate deficiency on hepatic folate-metabolizing enzymes in order to determine if the biochemical effect on folate metabolism caused by oestrogen is a decreased ability to interconvert folate coenzymes.
Pullets (1 day old) (H and N Nick Chicks) were communally fed on a commercial chick mash for 16 days in Expt.
(1) and 21 days in Expt. (2). They were then transferred to individual caged and fed on a purified, folk acid-deficient diet similar to that of Jackson (1972) with the vitamin E content increased to lSmg/kg and the inclusion of cellulose (57g/kg). After feeding the deficient diet for 22 days in Expt. (I) and 13 days in Expt. (2) the chickens were randomized among four treatment groups on a live-weight basis. Chickens in groups I and I11 received daily injections of folk acid (0.5mg) in 0.1~-phosphate buffer, pH7.4 (O.lml), and those in groups I1 and IV phosphate buffer only. Similarly chicks in groups I11 and IV were injected on alternate days with l7j-oestradiol dipropionate (2mg) in corn oil (0.2ml) and those in groups I and I1 with corn oil only. The folate and oestradiol injections were given intramuscularly over a 9-day period, during which the food intake of all the chickens was restricted to that of the folate-deficient groups. The birds were killed by decapitation 24h after receiving the final injections and enzyme extracts were prepared by homogenizing liver samples in 0.1 M-phosphate buffer, pH7.4, and centrifuging at 20000g for 30min at 0°-5"C. Dihydrofolate reductase (EC 1.5.1.3), serine hydroxymethyltransferase (EC 2.1.2.1), 5,10-methylenetetrahydrofolate dehydrogenase (EC 1.5.1 S), glutamate formiminotransferase (EC 2.1.2.5) and 10-formyltetrahydrofolate synthetase (EC 6.3.4.3) activities were measured by the methods of Mathews etal. (1963) , Scrimgeour & Huennekens(1962 ,1963 ), Tabor (1962 ) and Rabinowitz & Ricer (1963 respectively. The crude protein contents of the enzyme extracts were measured by a micro-Kjeldahl method. The statistical significances of the results were evaluated by analysis of variance, and each value presented in Tables 1 and 2 represents the mean of eight individual observations. Body, liver and oviduct weights after killing are shown in Table 1 . The oviduct-growth response to oestrogen is taken as a measure of the folate status of the chicks (Hertz, 1945) . Thus the results show that, in Expt. (l), when the folate-deficient diet was fed for a longer period, there was greater folate deficiency than in Expt. (2).
